CTN Dissemination Library

OV Node Summer Speaker Series: Endocannabinoid Regulation of Repeated Stress-Cocaine Interactions
2025-07-09 12:00 - 13:00 (America/New_York) | Webinar/Virtual
Join the University of Cincinnati College of Medicine Center for Addiction Research, part of the CTN Ohio Valley Node, is hosting a Summer Speaker Series. The series will highlight cutting-edge UC addiction research and UC-community collaborations related to prevention and treatment.
The second event in the series will be held on July 9, 2025, from 12-1pm ET:
Endocannabinoid Regulation of Repeated Stress-Cocaine Interactions
July 9, 2025, 12-1pm ET
Host: T. John Winhusen, PhD (University of Cincinnati)
Presenter: Jayme McReynolds, PhD, University of Cincinnati
Register here!

Western States Node Webinar: CTN-0108: Transcranial Magnetic Stimulation in the Treatment of Stimulant Use Disorder
2025-06-25 11:00 - 12:30 UTC | Webinar/Virtual
In this session, Kathleen T. Brady, MD, PhD, of the Medical University of South Carolina, will discuss the NIDA N Clinical Trials Network (CTN) study CTN-0108, “Transcranial Magnetic Stimulation for the Treatment of Methamphetamine/Cocaine Use Disorder,” a pilot study that aims to determine the feasibility, effectiveness, and safety for 20 sessions of repetitive transcranial magnetic stimulation (rTMS) versus sham in adults with a diagnosed methamphetamine or cocaine use disorder.
Dr. Brady, co-Principal Investigator for CTN-0108, will present the rationale for the study, including the literature supporting the use of rTMS in stimulant use disorder, as well as the study methodology and preliminary results.
Objectives:

List 3 key research findings supporting the use of TMS in treating substance use disorders
Describe at least 3 key elements of the methodology for a trial of TMS in treating simulant use disorders
Identify at least 3 preliminary data points from the CTN-0108 study

CME and CE credits available! Sponsored by the Western States Node and the Northwest and Pacific Southwest ATTCs.
About the presenter:
Kathleen T. Brady, M.D., Ph.D.
Distinguished University Professor
Director, South Carolina Clinical and Translational Research Institute
Medical University of South Carolina
Dr. Brady is an experienced clinical and translational researcher and has been conducting scientific investigations and clinical work in the field of addictions and psychiatric disorders for over 40 years. Her focus is on pharmacotherapy and neurobiology of addictions, comorbid psychiatric disorders and gender differences in addictions. She has received numerous federal research grants and has published over 400 peer-reviewed journal articles and edited/co-edited 10 books. She is the former Vice President for Research at the Medical University of South Carolina. She has been a member of AAAP for over 25 years and has served at the President of the Association for Medical Education and Research in Substance Use Disorders (AMERSA), the American Academy of Addiction Psychiatry (AAAP) and is the immediate past president of International Society of Addiction Medicine (ISAM).

College on Problems of Drug Dependence (CPDD) Annual Meeting
2025-06-14 - 2025-06-18
CPDD provides a national and international forum for scientists of diverse backgrounds to advance the understanding of molecular-neurobiological aspects of addictive disorders and, by the application of new scientific knowledge, to improve and develop treatments utilizing novel behavioral and pharmacological therapies.
Since 1938, a major focus of the CPDD’s activities has been its sponsorship of an annual scientific meeting. This conference serves as a forum bringing together basic scientists and clinical investigators from industry, academia, and government. Representatives of regulatory agencies, as well as scientists and professionals in a number of diverse disciplines interested in the biochemical, behavioral, and public health aspects of drug dependence participate.
Approximately 1,300 attendees are expected for the 2025 meeting, including many international attendees who come for the CPDD meeting as well as the NIDA International Forum.

Northeast Node Science Series Webinar: Digital Tools to Promote Substance Use Disorder and Mental Health Care (June 12, 2025, 12pm ET)
2025-06-12 12:00 - 13:00 (America/New_York) | Webinar/Virtual
1.0 CME, ANCC, or Vermont OPR CE credits available!
Advances in digital technology, such as mobile devices, have fundamentally changed our society and are rapidly changing how we provide substance use and mental healthcare.
In this webinar from the CTN Northeast Node, part of their ongoing Science Series, Dr. Lisa Marsch, Director of the Dartmouth Center for Technology and Behavioral Health, will discuss how digital technology can provide state-of-the science, personalized behavioral healthcare anytime and anywhere.
She will review how data collected from mobile devices can provide new insights into the dynamic nature of substance use and mental health disorders in people’s daily lives and provide personalized digital therapeutic interventions to complement and extend our traditional models of care. She will highlight the striking behavioral healthcare needs across the globe and how digital technologies can help provide scalable solutions to tackle these population-level needs. She will provide a vision for the potential of digital technology to help redefine the future of behavioral healthcare.
Register for the session here!

OV Node Summer Speaker Series: Forming an Interprofessional Workforce to Address Opioid Use Disorder Among At-Risk Youth
2025-06-11 12:00 - 13:00 (America/New_York) | Webinar/Virtual
Join the University of Cincinnati College of Medicine Center for Addiction Research, part of the CTN Ohio Valley Node, is hosting a Summer Speaker Series. The series will highlight cutting-edge UC addiction research and UC-community collaborations related to prevention and treatment.
The first session in the series will be held on June 11, 2025 from 12-1pm ET:
Forming an Interprofessional Workforce to Address Opioid Use Disorder Among At-Risk Youth
June 11, 2025, 12-1pm ET
Host: T. John Winhusen, PhD (University of Cincinnati)
Presenters:
Michael D. Brubaker, PhD, LICDC-CS, NCC, School of Human Services, University of Cincinnati
Kaycia Spenser, LISA, Cincinnati Children’s Hospital
Register here!

CTN Quarterly Steering Committee Meeting (Virtual)
2025-06-10 13:00 - 16:15 (America/New_York) | Webinar/Virtual
The Center for the Clinical Trials Network (CCTN) at the National Institute on Drug Abuse (NIDA) is hosting a virtual Quarterly Steering Committee Meeting on Tuesday, June 10, 2025 from 1:00 – 4:15 p.m. Eastern.

Register for the meeting | View the agenda

Once registered you will receive a confirmation email with a link to join the meeting and an option to download a calendar invitation.

Please note: The event platform has changed from Zoom to Teams. Please register for the meeting early as it can take up to five minutes for the system to recognize a new registration and allow access to the meeting. If you have any questions about the meeting logistics, please contact CTNSupport@sdsolutionsllc.com.

Individuals with disabilities who need sign language interpreting and/or other reasonable accommodations to participate in this event should contact Sean Randol at (202) 258-3638 or srandol@sdsolutionsllc.com or through the Federal Relay (1-800-877-8339). Requests should be made at least five business days in advance of the event.

CTN T&I SIG: Implementation of ED-Initiated Buprenorphine for Opioid Use Disorder
2025-05-20 09:00 - 10:00 (America/Los_Angeles) | Webinar/Virtual
Join the CTN Translation & Implementation (T&I) SIG on May 20, 2025 (9-10am PT) for their next meeting, featuring the work of CTN-0069: Opioid Use Disorder in the Emergency Department (Project ED Health).
Presenters Gail D’Onofrio, MD, MS, and David A. Fiellin, MD, will share their study approach and results, as well as considerations for integrating implementation outcome evaluations in efficacy/effectiveness protocols.
Interested in attending? Reach out to Elena Rosenberg-Carlson (rosenbee@stanford.edu) for the meeting link and/or to join the SIG listserv!
Read more about the presenters here (pdf)!

CTN Primary Care SIG webinar: Methadone in Primary Care
2025-05-19 12:00 - 13:00 (America/New_York) | Webinar/Virtual
The Primary Care SIG aims to engage primary care in research, develop substance use treatment interventions relevant to community-based practice, and promote the transfer of evidence-based results from substance use research into community-based practices.

Primary Care SIG Key Objectives

Make sure that CTN priorities for substance use research are informed by primary care practice

Provide consultation on CTN protocol/project development to ensure compatibility of the protocol, its recruitment process, and community-based practice, if possible

Link primary care practice to protocols as appropriate, including site recruitment support

Primary Care SIG Webinars and presentations

The Primary Care SIG is led by Sebastian Tong, MD, MPH, and meets every other month on the 4th Monday of the month from 9-10am PT/12-1pm ET.

To join the Primary Care SIG webinar series listserv, please provide your contact information here.

Next Primary Care SIG Meeting

Methadone in Primary Care
May 19, 2025

Claire Simon, MD
Clinician Researcher, FM
University of Washington

Paul Joudrey, MD, MPH
Assistant Professor, GIM

Register here!

American Psychiatric Association (APA) Annual Meeting
2025-05-17 - 2025-05-21
This year, APA welcomes attendees from around the world to the Los Angeles Convention Center in Los Angeles, California for five full days of mental health programming and the chance to reconnect with your peers and reinvigorate your practice. Virtual options will also be available. The conference will be held from May 17-21, 2025.
With 450+ educational sessions and paid courses covering over 28 topics, four plenaries, and 1,000+ posters, APA’s Annual Meeting is the best place to connect with colleagues, get the latest in scientific advances, and meet your certification and licensure requirements.
The meeting theme of 2025, “Lifestyle for Positive Mental and Physical Health,” will be the feature of a Lifestyle Psychiatry session track.

American Society of Addiction Medicine Annual Meeting
2025-04-24 - 2025-04-27
The ASAM Annual Conference is the defining event in addiction medicine bringing together all professionals to connect, learn, and inspire. For 56 years, ASAM has been convening the addiction treatment community to showcase best practices and the latest science, research, and innovations in the field.
This year’s conference will be held in Denver, CO, from April 24-27, 2025 with the theme “Innovations in Addiction Medicine and Science.”

Northeast Node Science Series: Cannabis: Therapeutic Use and Consequences
2025-04-10 12:00 - 13:00 (America/New_York) | Webinar/Virtual
The landscape of cannabis research has sharpened in recent years, with new understandings of what is therapeutically beneficial and what is not. There is a great diversity in cannabis products and nearly as many ways to consume it, with more US states seeking legalization of both medicinal and recreational use. In this presentation, Dr. Alan Budney will review the state of the science related to the clinical efficacy of cannabis use and discuss alternative ways to consider and act on what is known. He will also review the potential consequences of cannabis use for patients with substance use disorders and how we need to consider situational and individual context when evaluating risk and impact of cannabis consumption.

Primary Care SIG: Implementing Practice Facilitation to Enhance Chronic Pain and Opioid Management in Older Adults
2025-03-24 09:00 - 10:00 (America/Los_Angeles) | Webinar/Virtual
The Primary Care SIG aims to engage primary care in research, develop substance use treatment interventions relevant to community-based practice, and promote the transfer of evidence-based results from substance use research into community-based practices. In their next meeting, the following presenters will be speaking about “Implementing Practice Facilitation to Enhance Chronic Pain and Opioid Management in Older Adults”:

Zsolt Nagykaldi, PhD, BTh Professor, Director of Research Associate Director of Community Engaged Research Department of Family & Preventive Medicine University of Oklahoma Health Sciences Center

Juell Homco, PhD, MPH Assistant Professor Director of Research and Community Analytics Associate Director of Oklahoma Primary Healthcare Improvement Cooperative Department of Medical Informatics University of Oklahoma School of Community Medicine

Heather Gamble, BS Community Outreach Manager (Practice Facilitator) Oklahoma Shared Clinical and Translational Resources University of Oklahoma Health Sciences Center

CTN Youth SIG: Implications of Basic Emotion Science for Substance Use Treatment and Intervention
2025-03-21 11:00 - 12:00 UTC | Webinar/Virtual
Michelle “Lani” Shiota, Ph.D.
Professor, Department of Psychology
Director, Substance use and Addiction Translational Research Network (SATRN)
Arizona State University
Dr. Michelle “Lani” Shiota is a Professor of Psychology at ASU conducting research on positive emotions, emotion regulation, and emotion-related mechanisms of health behavior. As Director of SATRN@ASU she guides a network of academic researchers and community partners in promoting community-engaged and interdisciplinary addiction science as well as evidence-based practice. A former junior high science teacher and teen dance instructor, Dr. Shiota also brings a unique perspective on issues related to youth substance use.
Dr. Shiota’s presentation will delve into implications of basic emotion science for innovative, mechanistic research on substance use prevention, treatment, and harm reduction. Informed by psychology, neuroscience, and addiction science, the presentation will highlight distinct research questions revealed through this lens, as well as opportunities for intervention.

T&I SIG: A Pragmatic Measure of Context at the Organizational Level: The Inventory of Factors Affecting Successful Implementation and Sustainment
2025-03-18 09:00 - 10:00 (America/Los_Angeles) | Webinar/Virtual
Successful implementation and sustainment of interventions is heavily influence by context. Yet the complexity and dynamic nature of context make it challenging to connect and translate findings across implementation efforts, limiting potential replicability and utility. The Inventory of Factors Affecting Successful Implementation and Sustainment (IFASIS) was developed to be a pragmatic, quantitative, organizational-level assessment of contextual factors. The intention is to characterize context with a measure that may enhance replication and reproducibility of findings beyond single implementation case studies.
In this talk, the development and validation of the IFASIS will be presented, as well as examples of its practical utility.
Speaker: Helene Chokron Garneau, PhD, MPH (Senior Research Scientist at Stanford University School of Medicine and co-Director of the Center for Dissemination and Implementation At Stanford (C-DIAS).
To join the session, contact Elena Rosenberg-Carlson at rosenbee@stanford.edu

Virtual Quarterly CTN Steering Committee Meeting
2025-03-11 13:00 - 17:00 UTC | Webinar/Virtual
The National Institute on Drug Abuse (NIDA) Center for the Clinical Trials Network (CCTN) is hosting a virtual Quarterly Steering Committee Meeting on Tuesday, March 11, 2025 from 1:00 – 5:00 p.m. Eastern.

View agenda | Register for the meeting

Once registered you will receive the Zoom information, including an option to download a calendar invitation. If you have any questions about the meeting logistics, please contact CTNSupport@sdsolutionsllc.com.

Individuals with disabilities who need sign language interpreting and/or other reasonable accommodations to participate in this event should contact Sean Randol at (202) 258-3638 or srandol@sdsolutionsllc.com or through the Federal Relay (1-800-877-8339). Requests should be made at least five business days in advance of the event.

Western States Node: Cannabis Use During Pregnancy (1.5 CE/CME)
2025-02-12 11:00 - 12:30 (America/Los_Angeles) | Webinar/Virtual
In this webinar sponsored by the Western States Node and the Northwest and Pacific Southwest ATTCs, Kelly Young-Wolff, PhD, MPH (a licensed clinical psychologist and research scientist at the Kaiser Permanente Northern CA Division of Research) will describe what is known about prenatal cannabis use trends and health consequences using data from Kaiser Permanente Northern California’s large integrated healthcare delivery system. She will discuss why pregnant individuals use cannabis, describe disparities in prenatal cannabis use and related outcomes, and end with a discussion about the potential harms of punitive policies that penalize or criminalize prenatal substance use.
At the conclusion of the webinar, participants will be able to:

Describe at least two (2) trends relating to changing rates of prenatal cannabis use over time.
Explain at least three (3) reasons why pregnant individuals might be using cannabis.
Specify at least three (3) potential risks of using cannabis during pregnancy.

1.5 CME or CE credits available! (Select credit type when you register; learn more about available credit types here.)
Sponsored by the Northwest and Pacific Southwest Addiction Technology Transfer Centers (ATTCs) and the Western States Node of the NIDA Clinical Trials Network.

Northeast Node Science Series: ED Treatment of OUD: Innovation & Discovery
2025-02-06 09:00 - 10:00 (America/Los_Angeles) | Webinar/Virtual
Opioid use disorder (OUD) took the lives of an estimated 107,543 people in the United States in 2023, yet medications to treat OUD are effective and widely available. Emergency departments are a 24/7/365 option for combating this crisis and saving lives.
In this presentation, Dr. Gail D’Onofrio will discuss the evidence regarding initiation of buprenorphine in the ED, describe innovations in dosing and formulations (extended-release and high dose initiation), and discuss implementation strategies to improve uptake of evidence-based practices and integration into EDs across the country.
Register here!

Primary Care SIG Webinar: Engaging Rural Communities and Practices in Substance Use Research
2025-01-27 12:00 - 13:00 (America/New_York) | Webinar/Virtual
The NIH recently launched a $30 million Communities Advancing Research Equity (CARE) for Health Initiative, which funds primary care research network hubs to engage rural communities and practices in research. As part of the pilot, CTN-0139 (Co-Care) is engaging with two newly funded rural hubs to expand engagement and recruitment in small rural practices.
The January 27, 2025 Primary Care SIG meeting (12pm ET, 9am PT) will feature a panel to discuss how CARE for Health synergistically can enhance and contribute to CTN trials. The panel will include:

Representatives from the NIH team who lead the CARE for Health Initiative
Dr. Allison Cole, co-PI from one of the newly funded hubs
Dr. Jane Liebschutz, co-PI from CTN-0139 (Co-Care)

Connect to the Zoom meeting.
ID: 996 0835 1363
Passcode: [REDACTED]
Questions? Contact Maria Prado at pradom@uw.edu.

Youth SIG Webinar: Age, Period, and Cohort Effects in Alcohol and Other Substance Use
2025-01-17 11:00 - 12:00 (America/New_York) | Webinar/Virtual
Join the CTN Youth SIG for their next webinar, “Age, Period, and Cohort Effects in Alcohol and Other Substance Use: Implications for Health and Prevention,” presented by Katherine M. Keyes, PhD (Columbia University), on Friday, January 17, 2025, 11am-12pm ET.

Incidence, prevalence, and persistence of substance use differ by generation and by substance. Understanding how each generation uses alcohol and other drugs, why, and how health is implicated is critical for public health. The presentation will overview what we know about current trends in substance use, how rates are organized by age, period, and cohort, and how these trends are shaping public health overall.

About the presenter

Katherine M. Keyes, PhD, is Professor of Epidemiology at the Columbia University Mailman School of Public Health. Dr. Keyes’ research focuses on psychiatric and substance use epidemiology across the life course, including early and cross-generational origins of child and adult health and cohort effects on substance use, mental health, and injury outcomes including suicide and overdose. She is the author of more than 450 peer-reviewed publications, and two textbooks.

Northeast Node Webinar: Medications for OUD for Youth
2024-12-05 12:00 - 13:30 (America/New_York)
In 2021, one in every 100 kids aged 12-17 had an opioid use disorder (OUD). Medication treatment for OUD (MOUD) is effective, but only 3-4% of youth who need it receive treatment. This session will outline features of youth treatment for OUD, evidence for treating youth with medications, youth MOUD uptake and retention, the role of families in care, and opportunities for interdisciplinary care teams in outpatient settings.
In this extended session, Dr. Marc Fishman (Mountain Manor & Johns Hopkins) will also facilitate interactive case reviews with attendees. If you have a case you would like to present, please let Bethany McLeman know: bethany.m.mcleman@dartmouth.edu
Register here!

NIDA CTN - Future of AI in Medicine: Medical Imaging as an Example
2024-11-20 12:00 - 13:30 (America/New_York)
Join the NIDA CCTN on November 20 (12pm ET) for a webinar on the future of AI in medicine!

Presenter:
Dr. Curt Langlotz
Professor of Radiology, Medicine, and Biomedical Data Science
Senior Associate Vice Provost for Research
Director, Center for Artificial Intelligence in Medicine & Imaging
Senior Fellow, Institute for Human-Centered Artificial Intelligence

Artificial intelligence (AI) is an incredibly powerful tool for building systems that support the work of clinicians and researchers. Over the last decade, machine learning methods have revolutionized the analysis of medical data, leading to high interest and explosive growth in the use of AI and machine learning methods. These promising techniques create systems that perform some clinical tasks at the level of expert physicians. Deep learning methods in imaging are now being developed for image reconstruction, imaging quality assurance, imaging triage, computer-aided detection, computer-aided classification, and radiology report drafting. The systems have the potential to provide real-time assistance to radiologists and other imaging professionals, thereby reducing diagnostic errors, improving patient outcomes, and reducing costs. We will review the origins of AI and its applications to medicine, and medical imaging, define key terms, and show examples of real-world applications that suggest how AI may change the practice of medicine. We will also review key shortcomings and challenges that may limit the application of these new methods.

Learning objectives

Understand the origins of artificial intelligence and machine learning and their application to medical imaging

Predict how machine learning methods will change the practice of medicine using current examples from medical imaging

Describe how large language models will affect health care

Assess the shortcomings of artificial intelligence that may limit its applicability

About the presenter

Curtis P. Langlotz, MD, PhD : Dr. Langlotz is Professor of Radiology, Medicine, and Biomedical Data Science, and Senior Associate Vice Provost for Research at Stanford University. His NIH-funded laboratory develops machine learning methods to improve the accuracy and efficiency of medical image interpretation. He also serves as Senior Fellow at Stanford’s Institute for Human-Centered Artificial Intelligence and Director of the Center for Artificial Intelligence in Medicine and Imaging (AIMI Center), which supports over 200 faculty at Stanford who pursue interdisciplinary machine learning research to improve clinical care.

Register here!

CTN T&I SIG Webinar: Implementation Outcomes in NIDA Clinical Trials Network Studies
2024-11-19 09:00 - 10:00 (America/Los_Angeles)
Join the Translation and Implementation SIG on November 19th (9am-10am PT) for their next session, titled, “Implementation Outcomes in NIDA Clinical Trials Network Studies: A Systematic Review of Studies Conducted Over 25 Years in the CTN.”
This webinar will be presented by Sophia Gonzalez, MPH and Joe Glass, PhD, MSW of the CTN T&I Implementation Outcomes Workgroup and will focus on a study to explore and document the evolution of the inclusion of implementation outcomes across trials conducted within the CTN, characterize outcomes included, identify gaps and potential opportunities to strengthen implementation research within the CTN, and inform the broader field of SUD treatment.
Contact Helene Chokron Garneau at hchokgar@stanford.edu if you would like to attend!

CTN Youth SIG Webinar: Scaling Out Evidence-Based Interventions Through Primary Care Settings: the PAAS Program
2024-11-15 11:00 - 12:00 (America/New_York)
The CTN Youth SIG is pleased to invite you to an upcoming presentation/webinar:
Scaling out evidence-based interventions through primary care settings: A Case Study of the Pathways for African Americans (PAAS) Program
Presenter:
Velma McBride Murry, PhD
Lois Autrey Betts Endowed Chair
Co-Director, Vanderbilt University Medical Center Program for Health Equity Research
Distinguished University Professor, Departments of Health Policy & Human and Organizational Development, Vanderbilt University
This presentation will highlight the role of primary care setting as a conduit for evidence-based intervention access for families. In addition, attention will be given the need to focus on system level interventions to reduce the need for families and youth to be “resilient.”
About the presenter: Dr. Velma McBride Murry holds the Lois Autrey Betts Endowed Chair, previously held an appointed position of Associate Provost, Research and Innovation, currently serves as Co-Director of the Vanderbilt University Medical Center Program for Health Equity Research (PHER), and is a University Distinguished Professor in Departments of Health Policy [Vanderbilt School of Medicine] and Human and Organizational Development [Peabody College]. She is Past President of the Society for Research on Adolescence and current President of The International Consortium of Developmental Science Societies. McBride Murry is one of the 100 elected members to the 2020 Class of the National Academic of Medicine. She is an appointed standing member of National Institutes of Health National Advisory Mental Health Research Council. Her research examines the significance of context to everyday life experiences of African American families and youth, focusing on processes through which racism, and other social structural stressors, cascade through families to influence parenting and family functioning, developmental outcomes, and adjustment among youth, during critical developmental periods from middle childhood through young adulthood.
Register here!

American Public Health Association Annual Meeting
2024-10-27 - 2024-10-30 | Minneapolis Convention Center, 1301 Second Ave S, Minneapolis, MN, 55403, United States
The 2024 APHA Annual Meeting and Expo will take place in Minneapolis, MN on Oct. 27-30, 2024. The theme for this year’s event is “Rebuilding Trust in Public Health and Science.”
Public health is inherently future-focused, looking toward prevention and promotion to enable populations to live longer, healthier lives. But recent political polarization, underfunding and distrust of scientific research threaten our ability to create optimal, equitable health and well-being for all. The promise and effectiveness of public health is challenged by pseudoscience. Given this discord, we need to rebuild trust in public health and science.
Registration is open!
For more information, visit the conference website.

NIDA HIV Research Program Seminar Series: Let's Talk PrEP
2024-10-23 13:00 - 14:30 (America/New_York) | Webinar/Virtual
Questions about HIV PrEP and how it relates to people with substance use disorders?
The NIDA HIV Research Program has invited some HIV clinical research experts and people living with HIV and substance use disorders to join us in our next virtual Seminar, “Let’s Talk PrEP”, October 23rd, 1-2:30 pm.
The seminar includes Drs. Rupa Patel from Whitman-Walker Health and the CDC; Dr. Jaimie Meyer from Yale, and Dr. Hansel Tookes from the University of Miami.
Register here!

CTN Annual Scientific Meeting
2024-10-21 - 2024-10-23 | Crystal Gateway Marriott, 1700 Richmond Hwy, Arlington, VA, 22202, United States
The National Drug Abuse Treatment Clinical Trials Network (CTN) will hold its Annual Scientific Meeting celebrating the 25th Anniversary of the CTN on Monday-Wednesday, October 21-23, 2024.
The meeting will be held in person at the Crystal Gateway Marriott in Arlington, Virginia.
Plenary sessions and some breakouts will also be available virtually.
Registration, hotel, and session information available here!

Addiction Health Services Research (AHSR) Conference, 2024
2024-10-16 - 2024-10-18 | Palace Hotel, 2 New Montgomery St., San Francisco, CA, 94105, United States
The Addiction Health Services Research (AHSR) conference, held since 2005, brings together researchers, policymakers, and treatment providers to solve the problems of inequity, access, effectiveness, and implementation of addiction services.
This year, the conference is hosted by the Center for Dissemination and Implementation (CDI),a Stanford University initiative, at the historic Palace Hotel in the beautiful and bustling city of San Francisco, near quintessential landmarks including the cable cars and Chinatown.
For more information, visit the conference website.

Guam's 5th Annual Behavioral Health and Addictions Virtual Conference
2024-09-25 - 2024-09-26
The Guam Behavioral Health and Wellness Center and Pacific Southwest Addiction Technology Transfer Center cordially invite you to save the date for Guam’s 5th Annual Behavioral Health and Addictions Virtual Conference.
This live virtual conference is available at no-cost and is scheduled to take place during National Recovery Month on September 25-26, 2024 from 8:00am-2:30pm ChST.
QUESTIONS? Please contact Brandy Oeser at BOeser@mednet.ucla.edu
REGISTER HERE

CTN Primary Care SIG Webinar: The Odyssey of HOMER: Lessons from a Pragmatic Trial on Opioid Use Disorder Treatment in Primary Care
2024-09-23 12:00 - 13:00 (America/New_York)
Please join the CTN Primary Care SIG for their next meeting, featuring Linda Zittleman, MSPH and Don Nease, Jr., MD (both of University of Colorado Anschutz Medical Campus) presenting on a pragmatic trial on opioid use disorder treatment in primary care.
The Odyssey of HOMER: lessons from a pragmatic trial on opioid use disorder treatment in primary care
September 23, 2024
12-1pm EST
Join the webinar here (no registration required):
Passcode: [REDACTED]
Interested in presenting at a future Primary Care SIG meeting? Email Joe LeMaster at jlemaster@kumc.edu or Sebastian Tong at setong@uw.edu

Please contact Maria Prado at pradom@uw.edu for access to the meeting slides afterwards
If you have any questions about the meeting logistics, please contact CTNSupport@leedmci.com
Individuals with disabilities who need sign language interpreting and/or other reasonable accommodations to participate in this event should contact Sean Randol at (240) 863-0507 or srandol@leedmci.com or through the Federal Relay (1-800-877-8339). Requests should be made at least five business days in advance of the event.

CTN Youth SIG Webinar: Falling Through the Cracks: The Struggle of Adolescents with Opioid Use Disorder in the Face of Limited Treatment Options
2024-09-20 08:00 - 09:00 (America/Los_Angeles)
Presenter: Sivabalaji Kaliamurthy MD
Assistant Professor of Psychiatry, Howard University
Director, Addiction Program at Children’s National, Washington, DC
REGISTER HERE
In this presentation, Dr. Kaliamurthy will examine a case involving an adolescent who sought treatment within a pediatric health care system for fentanyl use. The focus will be on the challenges identified in delivering care to adolescents with opioid use disorder. He will also highlight barriers to treatment that must be overcome to deliver the minimum necessary care to ensure engagement in medication treatment for opioid use disorder and reducing overdose risk.
Dr. Kaliamurthy, a physician specialized in pediatric addictions, is board-certified in general psychiatry, child and adolescent psychiatry, addiction psychiatry and addiction medicine. He was pivotal in establishing the Addiction Clinic at Children’s National to treat children with psychiatric and substance use disorders. Dr. Kaliamurthy’s current research centers on evaluating the clinical outcomes associated with the use of medications for opioid use disorder in adolescents.
